Whole genome sequencing of influenza virus transmission pairs confirms the efficacy of baloxavir in reducing household transmission

Clicks: 3
ID: 324889
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #280 of 531 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 531 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The CENTERSTONE study demonstrated that treatment of influenza cases with baloxavir significantly reduced the transmission of influenza viruses to household contacts. Because transmission was defined based on the timing of test positivity and subtype match, it is possible that some events reflected co-incident community infection rather than within-household transmission. Such misclassification could affect the significance and magnitude of the baloxavir treatment effect. Methods Specimens from CENTERSTONE households with ≥2 influenza virus positive individuals were selected for whole genome sequencing. Consensus sequences and intrahost single nucleotide variants >2% frequency were determined. Phylogenetic trees of concatenated consensus sequences were constructed by subtype and study site country. Patristic differences between sequences were used to establish thresholds defining household transmission pairs. Results We obtained complete, high quality consensus genomes for 376/393 (96%) influenza A specimens and 39/64 (61%) influenza B specimens. Out of the 259 putative transmission pairs analyzed, we had reliable viral sequence data from both individuals in 145. 15/144 (10.4%) pairs had a distance ≥ 0.0005 (one was indeterminate), 17/145 (11.7%) pairs had a distance ≥0.0003, and 21/145 (14.5%) had a distance ≥0.0002. When excluding pairs based on the most stringent 0.0002 cut-off, the adjusted transmission incidence was 9.2% (95.38% CI, 7.2 - 11.8) and 12.9% (95.38% CI, 10.2 - 16.2) [aOR 0.69 (95.38% CI, 0.50-0.95)] in baloxavir vs. placebo groups, respectively. Conclusions Application of a stringent, sequence-based cutoff for defining true household pairs supports the outcome of the primary endpoint of CENTERSTONE. Baloxavir treatment of influenza cases can reduce influenza virus transmission in households.
Reference Key
openalex_W7202387353 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Adam S. Lauring, Leigh Papalambros, William J. Fitzsimmons, Emily E. Bendall, Aeron C. Hurt, Klaus Kuhlbusch, Eriola Berisha, Steffen Wildum
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag489
URL
https://doi.org/10.1093/cid/ciag489
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.